172 related articles for article (PubMed ID: 18327412)
1. Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations.
Tiede A; Tait RC; Shaffer DW; Baudo F; Boneu B; Dempfle CE; Horellou MH; Klamroth R; Lazarchick J; Mumford AD; Schulman S; Shiach C; Bonfiglio LJ; Frieling JT; Conard J; von Depka M
Thromb Haemost; 2008 Mar; 99(3):616-22. PubMed ID: 18327412
[TBL] [Abstract][Full Text] [Related]
2. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
[TBL] [Abstract][Full Text] [Related]
3. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women.
Folkeringa N; Brouwer JL; Korteweg FJ; Veeger NJ; Erwich JJ; Holm JP; van der Meer J
Br J Haematol; 2007 Feb; 136(4):656-61. PubMed ID: 17223916
[TBL] [Abstract][Full Text] [Related]
4. Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin.
Hoffmann JN; Wiedermann CJ; Juers M; Ostermann H; Kienast J; Briegel J; Strauss R; Warren BL; Opal SM;
Thromb Haemost; 2006 May; 95(5):850-6. PubMed ID: 16676077
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.
Keeney JA; Clohisy JC; Curry MC; Maloney WJ
J Arthroplasty; 2006 Jun; 21(4):469-75. PubMed ID: 16781396
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of venous thromboembolism in minor orthopedic surgery with parnaparin.
Montebugnoli M; Bugamelli S; Calò P; Zangheri E; Ferrari P
Clin Appl Thromb Hemost; 2007 Jul; 13(3):249-58. PubMed ID: 17636187
[TBL] [Abstract][Full Text] [Related]
8. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of the factor V Leiden paradox.
van Stralen KJ; Doggen CJ; Bezemer ID; Pomp ER; Lisman T; Rosendaal FR
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1872-7. PubMed ID: 18617648
[TBL] [Abstract][Full Text] [Related]
11. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
Turpie AG; Bauer KA; Davidson BL; Fisher WD; Gent M; Huo MH; Sinha U; Gretler DD;
Thromb Haemost; 2009 Jan; 101(1):68-76. PubMed ID: 19132191
[TBL] [Abstract][Full Text] [Related]
12. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis.
Bottaro FJ; Elizondo MC; Doti C; Bruetman JE; Perez Moreno PD; Bullorsky EO; Ceresetto JM
Thromb Haemost; 2008 Jun; 99(6):1104-11. PubMed ID: 18521515
[TBL] [Abstract][Full Text] [Related]
14. Combined anticoagulants ameliorate acute lung injury in sheep after burn and smoke inhalation.
Enkhbaatar P; Esechie A; Wang J; Cox RA; Nakano Y; Hamahata A; Lange M; Traber LD; Prough DS; Herndon DN; Traber DL
Clin Sci (Lond); 2008 Feb; 114(4):321-9. PubMed ID: 17927568
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of antithrombin administration in the acute phase of burn injury.
Lavrentieva A; Kontakiotis T; Bitzani M; Parlapani A; Thomareis O; Scourtis H; Tsotsolis N; Lazaridis L; Giala MA
Thromb Haemost; 2008 Aug; 100(2):286-90. PubMed ID: 18690349
[TBL] [Abstract][Full Text] [Related]
16. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
Debourdeau P; Chahmi DK; Zammit C; Farge-Bancel D
Pathol Biol (Paris); 2008 Jun; 56(4):211-9. PubMed ID: 18395994
[TBL] [Abstract][Full Text] [Related]
17. Deep vein thrombosis after total hip arthroplasty in Korean patients and D-dimer as a screening tool.
Yoo MC; Cho YJ; Ghanem E; Ramteke A; Kim KI
Arch Orthop Trauma Surg; 2009 Jul; 129(7):887-94. PubMed ID: 18825397
[TBL] [Abstract][Full Text] [Related]
18. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy.
Narin C; Reyhanoglu H; Tülek B; Onoglu R; Ege E; Sarigül A; Yeniterzi M; Durmaz I
Adv Ther; 2008 Jun; 25(6):585-94. PubMed ID: 18568442
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study.
Douketis J; Cook D; Meade M; Guyatt G; Geerts W; Skrobik Y; Albert M; Granton J; Hébert P; Pagliarello G; Marshall J; Fowler R; Freitag A; Rabbat C; Anderson D; Zytaruk N; Heels-Ansdell D; Crowther M;
Arch Intern Med; 2008 Sep; 168(16):1805-12. PubMed ID: 18779469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]